COMPASS THERAPEUTICS, INC. Investment Income, Interest
COMPASS THERAPEUTICS, INC. (CMPX) reported Investment Income, Interest of $6.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-03-05
- COMPASS THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-06-30 was $1.20M, a 40.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. investment income, interest for the quarter ending 2025-03-31 was $1.30M, a 35.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. investment income, interest for the quarter ending 2024-12-31 was $1.60M, a 20.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. investment income, interest for the quarter ending 2024-09-30 was $1.80M, a 10.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. investment income, interest for fiscal 2025 was $6.40M, a 12.33% decline from fiscal 2024.
- COMPASS THERAPEUTICS, INC. investment income, interest for fiscal 2024 was $7.30M, a 7.59% decline from fiscal 2023.
- COMPASS THERAPEUTICS, INC. investment income, interest for fiscal 2023 was $7.90M, a 234.75% increase from fiscal 2022.
- COMPASS THERAPEUTICS, INC. investment income, interest for fiscal 2022 was $2.36M, a 8037.93% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $6.40M 10-K · filed 2026-03-05 | |||||||
| 2025-06-30 | $1.20M 10-Q · filed 2025-08-11 | $2.50M 10-Q · filed 2025-08-11 | $4.10M derived: sum of 3 quarters · filed 2026-03-05 | $5.90M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2025-03-31 | $1.30M 10-Q · filed 2025-05-08 | $2.90M derived: sum of 2 quarters · filed 2026-03-05 | $4.70M derived: sum of 3 quarters · filed 2026-03-05 | $6.70M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.40M derived: sum of 2 quarters · filed 2026-03-05 | $5.40M derived: sum of 3 quarters · filed 2026-03-05 | $7.30M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $1.80M 10-Q · filed 2024-11-12 | $3.80M derived: sum of 2 quarters · filed 2025-08-11 | $5.70M 10-Q · filed 2024-11-12 | $7.80M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-06-30 | $2.00M 10-Q · filed 2025-08-11 | $4.00M 10-Q · filed 2025-08-11 | $6.00M derived: sum of 3 quarters · filed 2025-08-11 | $8.00M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $2.00M 10-Q · filed 2025-05-08 | $4.00M derived: sum of 2 quarters · filed 2025-05-08 | $6.00M derived: sum of 3 quarters · filed 2025-05-08 | $8.10M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.00M derived: sum of 2 quarters · filed 2025-02-27 | $6.10M derived: sum of 3 quarters · filed 2025-02-27 | $7.90M 10-K · filed 2025-02-27 | $7.87M 10-K · filed 2024-03-21 | |||
| 2023-09-30 | $2.00M 10-Q · filed 2024-11-12 | $1.96M 10-Q · filed 2023-11-09 | $4.10M derived: sum of 2 quarters · filed 2024-11-12 | $5.90M 10-Q · filed 2024-11-12 | $5.89M 10-Q · filed 2023-11-09 | $7.29M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $2.10M 10-Q · filed 2024-08-12 | $2.06M 10-Q · filed 2023-08-03 | $3.90M 10-Q · filed 2024-08-12 | $3.93M 10-Q · filed 2023-08-03 | $5.29M derived: sum of 3 quarters · filed 2024-08-12 | $5.92M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $1.90M 10-Q · filed 2024-05-13 | $3.19M derived: sum of 2 quarters · filed 2024-05-13 | $3.82M derived: sum of 3 quarters · filed 2024-05-13 | $4.24M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.92M derived: sum of 2 quarters · filed 2024-03-21 | $2.34M derived: sum of 3 quarters · filed 2024-03-21 | $2.36M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $623.00K 10-Q · filed 2023-11-09 | $1.05M derived: sum of 2 quarters · filed 2023-11-09 | $1.07M 10-Q · filed 2023-11-09 | $1.07M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $424.00K 10-Q · filed 2023-08-03 | $443.00K 10-Q · filed 2023-08-03 | $448.00K derived: sum of 3 quarters · filed 2023-08-03 | $449.00K derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $20.00K 10-Q · filed 2023-05-04 | $24.00K derived: sum of 2 quarters · filed 2023-05-04 | $25.00K derived: sum of 3 quarters · filed 2023-05-04 | $34.00K derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $5.00K derived: sum of 2 quarters · filed 2023-03-15 | $14.00K derived: sum of 3 quarters · filed 2023-03-15 | $29.00K 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-09 | $10.00K derived: sum of 2 quarters · filed 2022-11-09 | $25.00K 10-Q · filed 2022-11-09 | $43.00K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $9.00K 10-Q · filed 2022-08-01 | $24.00K 10-Q · filed 2022-08-01 | $42.00K derived: sum of 3 quarters · filed 2022-08-01 | $64.00K derived: sum of 4 quarters · filed 2022-08-01 | ||||
| 2021-03-31 | $15.00K 10-Q · filed 2022-05-09 | $33.00K derived: sum of 2 quarters · filed 2022-05-09 | $55.00K derived: sum of 3 quarters · filed 2022-05-09 | $62.00K derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $40.00K derived: sum of 2 quarters · filed 2022-03-18 | $47.00K derived: sum of 3 quarters · filed 2022-03-18 | $88.00K 10-K · filed 2022-03-18 | ||||
| 2020-09-30 | $22.00K 10-Q · filed 2021-11-12 | $29.00K derived: sum of 2 quarters · filed 2021-11-12 | $70.00K 10-Q · filed 2021-11-12 | $166.00K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $7.00K 10-Q · filed 2021-08-16 | $48.00K 10-Q · filed 2021-08-16 | $144.00K derived: sum of 3 quarters · filed 2021-08-16 | $320.00K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $41.00K 10-Q · filed 2021-04-30 | $137.00K derived: sum of 2 quarters · filed 2021-04-30 | $313.00K derived: sum of 3 quarters · filed 2021-04-30 | $550.00K derived: sum of 4 quarters · filed 2021-04-30 | ||||
| 2019-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $272.00K derived: sum of 2 quarters · filed 2021-03-05 | $509.00K derived: sum of 3 quarters · filed 2021-03-05 | $743.00K 10-K · filed 2021-03-05 | ||||
| 2019-09-30 | $176.00K 10-Q · filed 2020-11-09 | $413.00K derived: sum of 2 quarters · filed 2020-11-09 | $647.00K 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $237.00K 10-Q · filed 2020-08-13 | $471.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |